Typhoid Antibody Testing Market Trends

  • Report ID: 4164
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Typhoid Antibody Testing Market Trends

Growth Drivers

  • Increased Rate of Morbidity and Mortality – Typhoid is a deadly disease that can kill people at the same time a wide number of people get affected by it.  According to the data from the World Health Organization (WHO), around 11 – 20 million people are known to have typhoid disease. In this, between 128,000 and 161,000 people are known to die as a result of the disease every year.
  • Government Support to Manage Typhoid Cases – Government authorities in developing countries are supporting initiatives that promote proper sanitization. Developing countries or underdeveloped countries don’t have proper sanitization. Government authorities of the regions have introduced various programs and initiatives for proper sanitization to support the management of typhoid cases.  For instance, the “Swachh Bharat Mission” program was initiated by the Indian government and aims to improve sanitation conditions and waste management, as well as the construction of community toilets throughout the country by 2019.
  • Increased Collaboration among the Market Players – Several companies have gone through mergers and acquisitions to expand their product portfolios and increase their market share. Growing merger collaboration among the market players is expected to drive the growth of the typhoid antibody testing market in the future. For instance, in 2020 Abbott Laboratories acquired Alere Inc.'s diagnostics business. This included a range of products to test for typhoid antibodies. 

Challenges

  • Lacking Early Diagnosis of Enteric Symptoms – In 90% of cases it is seen that patients who are suffering from typhoid never get it diagnosed at an early age of symptoms. This is seen highly in Asia Pacific countries.
  • Lack of Awareness Related to Antibody Testing Kits
  • Patient’s Exposure to Other Antibiotics Before Visiting Healthcare Facility

Typhoid Antibody Testing Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

7.5%

Base Year Market Size (2023)

USD 1.08 Billion

Forecast Year Market Size (2036)

USD 2.75 Billion

Regional Synopsis

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4164
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of typhoid antibody testing is estimated at USD 1.15 Billion.

The typhoid antibody testing market size was valued at USD 1.08 Billion in 2023 and is expected to cross USD 2.75 Billion by the end of 2036, registering more than 7.5% CAGR during the forecast period i.e., between 2024-2036. Typhoid is on the rise in developing countries and increased competition among top competitors to produce fast and cost-effective diagnostic kits to diagnose typhoid cases is anticipated to boost the market growth.

Asia Pacific is set to hold the highest revenue share of 41% by 2036, driven by increase in typhoid cases in the region.

IDL Biotech AB, LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nectar Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., Siemens Healthcare GmbH, NanoEnTek, CerTest Biotec S.L.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying